CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to SNYNF

Fitusiran

Phase 3
Sanofi (SNYNF)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
SNYNFPhase 3
Completed

Fitusiran Phase 3 Est. Readout

Fitusiran
Aug 2026~
CT.gov
Competitive Landscape
Drug Information

Target Indication

Hemophilia

Clinical Trial

NCT03974113

Last updated: 3/31/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.